Michael Joseph Driscoll

Board Director

Director

Insider activity · 24 months1 buy1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 1 saleApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 1 buy · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (2 ops.)

€46k

▼ Sales (1 ops.)

€122k

Latest filing published 11 Mar 2026 for Organogenesis Holdings Inc., €23k. Read the official filing

Filing timeline

BuySale

Michael Joseph Driscoll

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-6.8%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Michael Joseph Driscoll: trading record in brief

All filings by Michael Joseph Driscoll on record concern Organogenesis Holdings Inc., in the capacity of board member. The record holds 8 filings, for trades running from 15 February 2022 to 9 March 2026.

Market trades split into 2 purchases (€46k) and 1 sale (€122k). Netting one side against the other leaves €75k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 share grants. Since January 2026: 1 purchase and no sales on the market.

On 11 March 2026 came the latest disclosure, an open-market purchase for €23k in Organogenesis Holdings Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.